How Do 5 Alpha Reductase Inhibitors Work?

5 alpha reductase inhibitors are a class of prescription drugs that block an enzyme your body uses to convert testosterone into a more potent hormone called dihydrotestosterone, or DHT. By lowering DHT, they slow or partially reverse certain effects that DHT has on the prostate and on hair follicles. Two drugs make up this class: finasteride and dutasteride. Both are FDA-approved, but for different conditions, and they work in slightly different ways.

How Do 5 Alpha Reductase Inhibitors Work?

They work by blocking the enzyme 5 alpha reductase, which normally converts testosterone into DHT. Less enzyme activity means less DHT in the tissues that depend on it.

DHT is an androgen — a male sex hormone — that is far more powerful than testosterone at the receptor level. It drives prostate growth and miniaturizes hair follicles in people who are genetically prone to male pattern hair loss. When you reduce DHT, those two processes slow down.

There are two main forms of the enzyme in the body: type 1 and type 2. Type 2 is the dominant form in the prostate and hair follicles. This distinction matters because the two drugs differ in which forms they block.

What Is the Difference Between Finasteride and Dutasteride?

Finasteride blocks only the type 2 enzyme. Dutasteride blocks both type 1 and type 2. That difference changes how much DHT each drug suppresses, but it does not automatically make one drug better for every person or every condition.

Both drugs belong to the same class and share the same core mechanism. The practical differences come down to approved uses, potency, and how long they stay in the body.

Greater DHT suppression does not necessarily translate into a better outcome for a given person. The relationship between how much DHT is blocked and how much symptoms improve is not perfectly linear, and individual response varies.

What Conditions Are These Drugs Used For?

These drugs are used for two main conditions: benign prostatic hyperplasia, often called an enlarged prostate, and androgenetic alopecia, the medical term for male pattern hair loss.

Benign Prostatic Hyperplasia (BPH)

BPH is a non-cancerous enlargement of the prostate that becomes common as men age. DHT is a key driver of this growth. By lowering DHT, these drugs can shrink the prostate over time and ease urinary symptoms such as a weak stream, frequent urination, and difficulty emptying the bladder.

The effect is gradual. Prostate size and symptom improvement typically take months, not days, to develop. This is different from alpha blockers, another common BPH treatment that relaxes prostate muscle and works within days but does not shrink the gland.

Male Pattern Hair Loss

In androgenetic alopecia, DHT binds to receptors in genetically susceptible hair follicles and gradually shrinks them, a process called miniaturization. Over time, the follicle produces thinner, shorter hairs until it stops producing visible hair. Lowering DHT can slow this process and, in some people, allow partial regrowth.

Finasteride is FDA-approved for this use in men. Dutasteride is not approved for hair loss in the US, though some clinicians prescribe it off-label. Response varies widely. Some men see noticeable change; others see little. Hair that has already been lost to a fully dormant follicle generally does not come back.

How Long Do They Take to Work?

These drugs do not produce immediate results. DHT levels drop within hours to days of starting treatment, but the tissue changes that follow take much longer.

• Prostate symptoms: Improvement often develops over several months, with the full effect on prostate size taking up to six months or longer.
• Hair loss: Visible change usually takes several months, and it can take a year or more to judge whether the drug is helping.

Stopping the drug reverses the DHT suppression. DHT levels return to baseline, and any benefit to the prostate or hair typically fades over time. This is why these medications are generally taken long term when they are working.

What Are the Side Effects?

The most commonly reported side effects relate to sexual function: reduced libido, erectile difficulties, and reduced ejaculate volume. In clinical studies, these were uncommon, and in most cases they resolved after stopping the drug. Some men also report breast tenderness or enlargement.

A smaller number of people report side effects that persist after stopping the medication. This is an area of real debate. The evidence is mixed, and researchers do not fully agree on how often it happens or why. It is a genuine concern that deserves an honest conversation with a clinician rather than a dismissal or an exaggeration.

These drugs also lower PSA, the protein used to screen for prostate cancer. This matters because a lowered PSA can mask a rising PSA. Clinicians who prescribe these drugs typically account for this by adjusting how they interpret PSA results. Anyone taking finasteride or dutasteride should tell their doctor so PSA readings are read correctly.

Who Should Be Cautious About Taking Them?

These medications are not appropriate for everyone. Several groups need extra caution or should avoid them entirely.

• Pregnant or potentially pregnant women: These drugs can cause serious harm to a male fetus. Pregnant women should not handle crushed or broken tablets, and should not take these drugs.
• People with liver disease: The liver processes these drugs, so impaired liver function can affect how the body handles them.
• Men with a rising or elevated PSA: This needs evaluation before starting treatment, since the drug can change PSA readings.

Anyone considering these drugs should review their full medication list and health history with a clinician. This is not a decision to make on your own.

Do They Treat Prostate Cancer?

No. These drugs are not a treatment for prostate cancer. They are used for benign prostate enlargement and, in the case of finasteride, for male pattern hair loss.

There is a more complicated question about whether they reduce the risk of developing prostate cancer. Some large trials found a lower overall rate of prostate cancer in men taking finasteride, but also a higher rate of a more aggressive form among those who did develop it. How to interpret this finding is still debated, and it is not a reason to take these drugs as a cancer prevention strategy. That decision belongs with a urologist, not a general assumption.

What Should You Know Before Starting?

These drugs are well-established for their approved uses, and their core mechanism — blocking the conversion of testosterone to DHT — is not in dispute. What varies is how much any individual benefits and how they tolerate it.

Two points are worth holding onto. First, results take time, and patience matters when judging whether the drug is working. Second, side effects are usually uncommon and reversible, but persistent effects are reported by some people and the evidence on this is genuinely unsettled. An honest conversation with a clinician about your specific situation is more useful than any general rule.